Recommendations for the Use of Prolonged-Release Fampridine in Patients with Multiple Sclerosis (MS)

Jana Lizrova Preiningerova, Ulf Baumhackl, Tunde Csepany, Adam Czaplinski, Florian Deisenhammer, Tobias Derfuss, Tanja H. Fabjan, Franz Fazekas, Siegrid Fuchs, Eva Havrdova, Alenka Horvath Ledinek, Zsolt Illes, Sasa Sega Jazbec, Eleonora Klimova, Samuel Komoly, Egon Kurca, Michael Linnebank, Lubomir Lisy, Jan Mares, Lubica ProchazkovaRozsa Csilla, Jarmila Szilasiova, Pavel Stourac, Radomir Talab, Peter Turcani, Marta Vachova, Laszlo Vecsei, David Vodusek, Olga Zapletalova, Thomas Berger

Research output: Article

9 Citations (Scopus)

Abstract

Summary: Prolonged-release fampridine (fampridine PR) is a potassium channel blocker that improves conductivity of signal on demyelinated axons in central nervous system. Fampridine PR has been approved to improve speed of walking in patients with multiple sclerosis. This statement provides a brief summary of data on fampridine PR and recommendations on practical use of the medication in clinical practice, prediction, and evaluation of response to treatment and patient management.

Original languageEnglish
Pages (from-to)302-306
Number of pages5
JournalCNS Neuroscience and Therapeutics
Volume19
Issue number5
DOIs
Publication statusPublished - máj. 2013

    Fingerprint

ASJC Scopus subject areas

  • Pharmacology
  • Psychiatry and Mental health
  • Physiology (medical)
  • Pharmacology (medical)

Cite this

Preiningerova, J. L., Baumhackl, U., Csepany, T., Czaplinski, A., Deisenhammer, F., Derfuss, T., Fabjan, T. H., Fazekas, F., Fuchs, S., Havrdova, E., Ledinek, A. H., Illes, Z., Jazbec, S. S., Klimova, E., Komoly, S., Kurca, E., Linnebank, M., Lisy, L., Mares, J., ... Berger, T. (2013). Recommendations for the Use of Prolonged-Release Fampridine in Patients with Multiple Sclerosis (MS). CNS Neuroscience and Therapeutics, 19(5), 302-306. https://doi.org/10.1111/cns.12101